Want to see NEOG full AI Analyst Report?
NEOG Stock Chart & Stats
$9.51
-$0.08(-0.62%)
At close: 4:00 PM EST
$9.51
-$0.08(-0.62%)
Day’s Range― - ―
52-Week Range$4.56 - $11.43
Previous CloseN/A
Volume665.40K
Average Volume (3M)2.53M
Market Cap
$2.25B
Enterprise Value$3.08K
Total Cash (Recent Filing)$159.90M
Total Debt (Recent Filing)$793.30M
Price to Earnings (P/E)―
Beta1.02
Next Earnings
Jul 28, 2026EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.80
Shares Outstanding217,673,030
10 Day Avg. Volume2,139,931
30 Day Avg. Volume2,527,052
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.61
Price to Sales (P/S)1.42
P/FCF Ratio-27.42
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$12.00Price Target Upside26.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.3
Revenue Forecast (FY)$849.08M
Bulls Say, Bears Say
Bulls Say
Recurring Consumables-driven RevenueNeogen’s core business sells consumable test kits and reagents used in routine safety workflows, creating repeatable demand tied to production volume and regulation. This recurring consumables model supports steady unit demand, predictable refill revenue and durable cash generation versus one-time sales.
Food Safety Segment Growth And Product StrengthConsistent core growth in Food Safety, led by high-growth indicator and pathogen kits, signals product-market fit and sticky customer adoption. Because Food Safety is driven by regulatory and quality spend, segment momentum supports margin sustainability and recurring consumable demand over the medium term.
Improving Cash Flow And Planned Divestiture To Cut LeveragePositive free cash flow combined with a planned $160M genomics divestiture provides a credible path to materially reduce net leverage. Improved cash generation and lower debt should increase financial flexibility to fund Petrifilm ramp, targeted R&D and transformation investments over the coming 6–12 months.
Bears Say
Severely Deteriorated ProfitabilityTrailing profitability has collapsed to deeply negative net margins, eroding retained earnings and ROE. Sustained losses impair the company’s ability to self-fund restructuring and R&D, increase reliance on debt or asset sales, and raise execution risk for multi-year transformation plans.
Animal Safety Supply And Margin DisruptionThird-party supplier failures caused material revenue decline and negative sample collection margins. Persistent supplier quality and sourcing issues threaten recurring service revenues and customer confidence in Animal Safety, making margin recovery and sustained growth in that segment uncertain.
Elevated Leverage And Weak ReturnsAlthough leverage has modestly improved, gross debt remains large versus cash and profitability is negative, producing very weak ROE. This constrains strategic optionality, raises refinancing and covenant risk if losses persist, and limits ability to invest ahead of the Petrifilm ramp until balance sheet repair is complete.
Neogen News
NEOG FAQ
What was Neogen’s price range in the past 12 months?
Neogen lowest stock price was $4.56 and its highest was $11.43 in the past 12 months.
What is Neogen’s market cap?
Neogen’s market cap is $2.25B.
When is Neogen’s upcoming earnings report date?
Neogen’s upcoming earnings report date is Jul 28, 2026 which is in 10 days.
How were Neogen’s earnings last quarter?
Neogen released its earnings results on Apr 09, 2026. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of $0.058 by $0.032.
Is Neogen overvalued?
According to Wall Street analysts Neogen’s price is currently Undervalued.
Does Neogen pay dividends?
Neogen does not currently pay dividends.
What is Neogen’s EPS estimate?
Neogen’s EPS estimate is 0.06.
How many shares outstanding does Neogen have?
Neogen has 217,673,030 shares outstanding.
What happened to Neogen’s price movement after its last earnings report?
Neogen reported an EPS of $0.09 in its last earnings report, beating expectations of $0.058. Following the earnings report the stock price went down -2.95%.
Which hedge fund is a major shareholder of Neogen?
Currently, no hedge funds are holding shares in NEOG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Neogen Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.00 (26.18% Upside)
$12.00 (26.18% Upside)
Blogger Sentiment
Bullish
NEOG Sentiment 100%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Decreased
By 1.9M Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
42.44%
12-Months-Change
Fundamentals
Return on Equity
-29.00%
Trailing 12-Months
Asset Growth
-16.78%
Trailing 12-Months
Company Description
Neogen
Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.
NEOG Stock 12 Month Forecast
Average Price Target
$12.00
▲(26.18% Upside)
Technical Analysis
Ownership Overview
0.60% Insiders
29.06% Mutual Funds
0.05% Other Institutional Investors
39.56% Public Companies and
Individual Investors